Detalles de la búsqueda
1.
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Ann Oncol
; 35(1): 66-76, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37866811
2.
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
Ann Oncol
; 33(5): 466-487, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176458
3.
Lung optimized treatment with CyberKnife® in inoperable lung cancer patients: feasibility analysis of a mono-institutional 115 patient series.
Neoplasma
; 67(3): 684-691, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32182088
4.
CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials.
Ann Oncol
; 29(3): 687-693, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29293889
5.
Anti-TIGIT to overcome resistance to immune checkpoint inhibitors in lung cancer: limits and potentials.
Ann Oncol
; 33(2): 119-122, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34839015
6.
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial.
Ann Oncol
; 27(3): 417-23, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26646759
7.
Testing for COVID-19 in lung cancer patients.
Ann Oncol
; 31(7): 832-834, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32278879
8.
Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT).
ESMO Open
; 8(2): 101192, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36965261
9.
Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers.
Clin Lung Cancer
; 24(1): e19-e26, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372676
10.
Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III study.
Ann Oncol
; 23(8): 2082-2087, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22730101
11.
First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology.
ESMO Open
; 7(1): 100355, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34922299
12.
The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report.
ESMO Open
; 7(5): 100572, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108559
13.
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.
Ann Oncol
; 22(7): 1528-1534, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21212155
14.
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial.
ESMO Open
; 6(2): 100051, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33611164
15.
Concomitant ALK translocation and other non-EGFR gene in NSCLC: knowledge in the making.
Ann Oncol
; 26(6): 1270-1271, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25791634
16.
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms.
Lung Cancer
; 148: 149-158, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32916569
17.
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.
Clin Transl Oncol
; 22(4): 603-611, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31254252
18.
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy.
Clin Transl Oncol
; 22(4): 621, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31432394
19.
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts.
Lung Cancer
; 146: 6-11, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32485661
20.
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts.
Radiother Oncol
; 149: 84-88, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32445987